VIPBG News

Dr. Kaitlin Bountress, along with other MPIs Drs. Gretchen Neigh, Peter Hamilton, and Mathew Banks, were awarded a R34 through NIH/NIDA R34 (R34DA061267).
This project seeks to establish a multidisciplinary and functionally diverse team and generate preliminary data across-species (i.e., in rat, human data) in order to improve our understanding of behavioral biomarkers and genetic risk factors for neurocognitive behaviors related to substance use disorder risk. The ultimate goal of this line of work is to improve our understanding of the causal mechanisms related to how early life socioenvironmental factors influence neurocognitive development and risk phenotypes for substance use disorder may help identify novel therapeutic targets.

Read more about this study at the NIH RePORTER.